Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2012; 18(20): 2586-2590
Published online May 28, 2012. doi: 10.3748/wjg.v18.i20.2586
Published online May 28, 2012. doi: 10.3748/wjg.v18.i20.2586
Figure 5 Clinical course of the patient.
After lamivudine administration, his liver function gradually improved despite repeated treatments for hepatocellular carcinoma (HCC), and his indocyanine green at 15 min after injection (ICGR15) test score was 5% 4 years after initiation of lamivudine treatment. He underwent a successful right hepatectomy for HCC 5 years after beginning lamivudine treatment. alb: Albumin; PT: Prothrombin time; TACE: Transcatheter arterial chemoembolization; RFA: Radiofrequency ablation; 5-FU: 5-Fluorouracil; CDDP: Cisplatin.
- Citation: Honda K, Seike M, Maehara SI, Tahara K, Anai H, Moriuchi A, Muro T. Lamivudine treatment enabling right hepatectomy for hepatocellular carcinoma in decompensated cirrhosis. World J Gastroenterol 2012; 18(20): 2586-2590
- URL: https://www.wjgnet.com/1007-9327/full/v18/i20/2586.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i20.2586